{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct01658501",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct01658501",
  "name": "Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM",
  "aliases": [
    "NCT01658501"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 593 participants.",
  "summary_technical": "Registry record NCT01658501. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-07 (actual). Results not posted.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-10-26",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT01658501",
      "normalized_value": "NCT01658501",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "diabetes-and-metabolic-disease"
      ],
      "system": [
        "metabolism"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; randomized; quadruple masking; primary purpose treatment",
    "drug_phase": "2",
    "registry_statuses": [
      {
        "status": "COMPLETED",
        "snapshot": "cardio:ctgov-nct01658501-2015-12-07"
      }
    ],
    "start_date": {
      "date": "2012-07",
      "type": null,
      "snapshot": "cardio:ctgov-nct01658501-2015-12-07"
    },
    "primary_completion_date": {
      "date": "2013-07",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct01658501-2015-12-07"
    },
    "completion_date": {
      "date": "2013-07",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct01658501-2015-12-07"
    },
    "results_first_posted": null,
    "countries": [
      {
        "code": "US",
        "snapshot": "cardio:ctgov-nct01658501-2015-12-07"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 593,
        "basis": "enrolled",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct01658501-2015-12-07"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Condition",
        "value": "Type 2 Diabetes Mellitus",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Intervention (Drug)",
        "value": "50 mg PB1023",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "70 mg PB1023",
        "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "100 mg PB1023",
        "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Placebo (0.9% Sodium Chloride)",
        "locator": "protocolSection.armsInterventionsModule.interventions[3].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Victoza®",
        "locator": "protocolSection.armsInterventionsModule.interventions[4].name"
      },
      {
        "label": "Intervention (Other)",
        "value": "Diet and Exercise",
        "locator": "protocolSection.armsInterventionsModule.interventions[5].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Metformin",
        "locator": "protocolSection.armsInterventionsModule.interventions[6].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Sulfonylurea",
        "locator": "protocolSection.armsInterventionsModule.interventions[7].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Metformin and Sulfonylurea",
        "locator": "protocolSection.armsInterventionsModule.interventions[8].name"
      },
      {
        "label": "Lead sponsor",
        "value": "PhaseBio Pharmaceuticals Inc.",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      }
    ]
  },
  "content_digest": "7fb11ce08415198ad81149726cb858c935b22fb3b9baf41a9a78df88487393d9",
  "review": {
    "content_digest": "7fb11ce08415198ad81149726cb858c935b22fb3b9baf41a9a78df88487393d9",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:type-2-diabetes",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01658501-2015-12-07",
          "locator": "derivedSection.conditionBrowseModule.meshes[0].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct01658501/",
  "context_path": "api/v1/context/cardio--ct-nct01658501.md"
}
